| In vitro activity profiling of Cumyl‐PEGACLONE variants at the CB1 receptor: Fluorination versus isomer exploration L Janssens, A Cannaert, MJ Connolly, H Liu, CP Stove Drug testing and analysis 12 (9), 1336-1343, 2020 | 20 | 2020 |
| Sensing an oxygen sensor: Development and application of activity-based assays directly monitoring HIF heterodimerization LK Janssens, CP Stove Analytical Chemistry 93 (43), 14462-14470, 2021 | 15 | 2021 |
| Machine learning to assist in large-scale, activity-based synthetic cannabinoid receptor agonist screening of serum samples LK Janssens, D Boeckaerts, S Hudson, D Morozova, A Cannaert, ... Clinical Chemistry 68 (7), 906-916, 2022 | 8 | 2022 |
| Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA LK Janssens, A Ametovski, E Sparkes, R Boyd, F Lai, CJ Maloney, ... ACS chemical neuroscience 14 (1), 35-52, 2022 | 6 | 2022 |
| Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites LK Janssens, S Hudson, DM Wood, C Wolfe, PI Dargan, CP Stove Archives of Toxicology 96 (11), 2935-2945, 2022 | 3 | 2022 |
| Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays—and how this matters for the harm … LK Janssens, K Van Uytfanghe, JB Williams, KW Hering, DM Iula, ... Archives of Toxicology, 1-12, 2024 | 2 | 2024 |
| Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay LK Janssens, L De Wilde, P Van Eenoo, CP Stove Analytical Chemistry 96 (1), 238-247, 2023 | 2 | 2023 |
| The ‘ABC’of split-nanoluciferase HIF heterodimerization bioassays: Applications, benefits & considerations LK Janssens, CP Stove Biochemical Pharmacology, 116478, 2024 | | 2024 |
| Interpreting mono-and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure LK Janssens, MJ Sommer, KE Grafinger, M Hermanns-Clausen, ... Archives of Toxicology, 1-14, 2024 | | 2024 |
| Towards better understanding SCRAs and metabolites in recreational drug intoxications associated with 5F-MDMB-PICA use LK Janssens, S Hudson, DM Wood, C Wolfe, PI Dargan, CP Stove Toxicologie Analytique et Clinique 34 (3), S123, 2022 | | 2022 |
| Large-scale activity-based SCRA screening on patient serum samples: CB1 bioassay supported by machine learning LK Janssens, D Boeckaerts, S Hudson, D Morozova, A Cannaert, ... Toxicologie Analytique et Clinique 34 (3), S51, 2022 | | 2022 |
